External quality assessment in molecular immunohematology: The INSTAND proficiency test program

Transfusion

Volumn 53, Issue 11 PART 2, 2013, Pages 2850-2858

  Flegel, Willy A ^a   Chiosea, Ion ^a   Sachs, Ulrich J ^b   Bein, Gregor ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ABO SYSTEM;

BLOOD BANK; BLOOD GROUP ABO SYSTEM; BLOOD GROUP TYPING; ERYTHROCYTE; EUROPE; GENETICS; GOOD LABORATORY PRACTICE; GRANULOCYTE; HUMAN; IMMUNOLOGY; STANDARDS; THROMBOCYTE; ARTICLE; STANDARD;

ABO BLOOD-GROUP SYSTEM; BLOOD BANKS; BLOOD GROUPING AND CROSSMATCHING; BLOOD PLATELETS; ERYTHROCYTES; EUROPE; GRANULOCYTES; HUMANS; LABORATORY PROFICIENCY TESTING;

EID: 84893177637     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12414     Document Type: Review

References (55)

1. Denomme GA, Flegel WA. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008;48: 2461-75.
2. Hillyer CD, Shaz BH, Winkler AM, Reid M. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008;22: 117-32.
3. Moulds JM. Future of molecular testing for red blood cell antigens. Clin Lab Med 2010;30: 419-29.
4. Castilho L. Applying molecular immunohematology discoveries to daily transfusion practice. Rev Bras Hematol Hemoter 2012;34: 184-5.
5. Flegel WA, Johnson ST, Keller MA, Klapper EB, Khuu HM, Moulds JM, Seltsam AW, Stack GS, Louis M, Tormey CA, Wagner FF, Weinstock C, Yazer MH, Denomme GA. Molecular immunohematology round table discussions at the AABB Annual Meeting, Boston 2012. Blood Transf, in press.
6. Wenk RE, Chiafari PA. DNA typing of recipient blood after massive transfusion. Transfusion 1997;37: 1108-10.
7. Legler TJ, Eber SW, Lakomek M, Lynen R, Maas JH, Pekrun A, Repas-Humpe M, Schröter W, Köhler M. Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients. Transfusion 1999;39: 852-5.
8. Cartron JP. Rh DNA - coordinator's report. Transfus Clin Biol 1996;3: 491-5.
9. Teramura G, Slichter SJ. Report on the sixth international society of blood transfusion platelet serology workshop. Transfusion 1996;36: 75-81.
10. Panzer S, Kaplan C. Report on the 1997 International Society of Blood TransfusionWorkshop for Genotyping of Platelet Alloantigens. Platelet and GranulocyteWorkshop ISBT. Transfus Med 1998;8: 125-8.
11. Bux J, Chapman J. Report on the second international granulocyte serology workshop. Transfusion 1997;37: 977-83.
12. Kroll H, Carl B, Santoso S, Bux J, Bein G. Workshop report on the genotyping of blood cell alloantigens. Transfus Med 2001;11: 211-9.
13. Kroll H, Flegel WA, Santoso S, Sachs UJ, Bein G. DGTI workshops for the molecular diagnosis of platelet, granulocyte and red blood cell polymorphism [abstract]. Transfus Med Hemother 2003;30(Suppl 1):9.
14. Kroll H, Mutz S, Gassner C, Flegel WA, Sachs UJ, Bein G. DGTI workshops 2003 for the molecular diagnosis of red blood cell, platelet and granulocyte alloantigens [abstract]. Transfus Med Hemother 2004;31(Suppl 3):5.
15. Kroll H, Mutz S, Gassner C, Flegel WA, Bein G. DGTI workshops 2003 for the molecular diagnosis of red blood cell, platelet and granulocyte alloantigens [abstract]. Transfus Med Hemother 2005;32(Suppl 1): 22-3.
16. Kroll H, Mutz S, Gassner C, Wagner FF, Jorks S, Bein G. DGTI workshops 2005 for the molecular diagnosis of red blood cell, platelet and granulocyte alloantigens [abstract]. Transfus Med Hemother 2006;33(Suppl 1): 31.
17. Sonneborn H-H, Darda C, Ernst M, Flegel WA, Helmbold W, Kasulke D, Kühnl P, Mueller-Eckhardt C, Northoff H, Poschmann A, Sonneborn HH. Results of the DGTI workshop on the evaluation of the reactivity of monoclonal anti-D. Infusionsther Transfusionsmed 1992;30: 382-7.
18. Legler TJ, Kroll H, Wagner FF, Flegel WA, Hallensleben M. Indikation und Durchführung einer Genotypisierung erythrozytärer Antigene [Indication and method of red cell antigen genotyping]. Infusionsther Transfusionsmed 2000; 27: 215-6.
19. Allen TC, Hammond ME, Robboy SJ. Quality and the college of american pathologists. Arch Pathol Lab Med 2011;135:1441-SA.
20. Daniels G, van der Schoot CE, Olsson ML. Report of the First InternationalWorkshop on molecular blood group genotyping. Vox Sang 2005;88: 136-42.
21. Daniels G, van der Schoot CE, Olsson ML. Report of the Second InternationalWorkshop on molecular blood group genotyping. Vox Sang 2007;93: 83-8.
22. Daniels G, van der Schoot CE, Gassner C, Olsson ML. Report of the third international workshop on molecular blood group genotyping. Vox Sang 2009;96: 337-43.
23. Daniels G, van der Schoot CE, Olsson ML. Report of the fourth InternationalWorkshop on molecular blood group genotyping. Vox Sang 2011;101: 327-32.
24. Denomme GA, Reid M. Inaugural meeting of the consortium for blood group genes (CBGG): a summary report. Immunohematology 2005;21: 129-31.
25. Reid ME, Westhoff CM, Denomme G, Castilho L. Consortium for Blood Group Genes (CBGG): Miami 2006 report. Immunohematology 2007;23: 81-4.
26. Denomme GA, Westhoff CM, Castilho L, Reid ME. Consortium for Blood Group Genes (CBGG): 2008 report. Immunohematology 2009;25: 75-80.
27. Reid ME, Westhoff C, Denomme G, Castilho L. Consortium for Blood Group Genes (CBGG): 2007 report. Immunohematology 2007;23: 165-8.
28. Denomme GA, Westhoff CM, Castilho LM, St-Louis M, Castro V, Reid ME. Consortium for Blood Group Genes (CBGG): 2009 report. Immunohematology 2010;26: 47-50.
29. Reinauer H, Wood WG. External quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity. Ger Med Sci 2005;3:Doc02.
30. Bundesärztekammer. Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen (Rili-BÄK). Dtsch Ärzteblatt 2013;110: 1056.
31. Greinacher A, Wesche J, Hammer E, Furll B, Volker U, Reil A, Bux J. Characterization of the human neutrophil alloantigen-3a. Nat Med 2010;16: 45-8.
32. Muschter S, Berthold T, Greinacher A. Developments in the definition and clinical impact of human neutrophil antigens. Curr Opin Hematol 2011;18: 452-60.
33. Sachs UJ, Reil A, Bauer C, Bux J, Bein G, Santoso S. Genotyping of human neutrophil antigen-5a (Ond). Transfus Med 2005;15: 115-7.
34. Kissel K, Scheffler S, Kerowgan M, Bux J. Molecular basis of NB1 (HNA-2a, CD177) deficiency. Blood 2002;99: 4231-3.
35. Storry JR, Castilho L, Daniels G, Flegel WA, Garratty G, Francis CL, Moulds JM, Moulds JJ, Olsson ML, Poole J, Reid ME, Rouger P, van der Schoot E, Scott M, Smart E, Tani Y, Yu LC, Wendel S, Westhoff C, Yahalom V, Zelinski T. International Society of Blood TransfusionWorking Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang 2011;101: 77-82.
36. Wagner FF. The RhesusBase. Ulm: DRK-Blutspendedienst Baden- Württemberg - Hessen; 1998.
37. Metcalfe P, Watkins NA, Ouwehand WH, Kaplan C, Newman P, Kekomaki R, De Haas M, Aster R, Shibata Y, Smith J, Kiefel V, Santoso S. Nomenclature of human platelet antigens. Vox Sang 2003;85: 240-5.
38. Bux J. Human neutrophil alloantigens. Vox Sang 2008;94: 277-85.
39. Stroncek D. Neutrophil alloantigens. Transfus Med Rev 2002;16: 67-75.
40. Robinson J, Waller MJ, Stoehr P, Marsh SG. IPD-the immuno polymorphism database. Nucleic Acids Res 2005; 33(Database issue):D523-D526.
41. Carl B, Kroll H, Bux J, Bein G, Santoso S. B-lymphoblastoid cell lines as a source of reference DNA for human platelet and neutrophil antigen genotyping. Transfusion 2000;40: 62-8.
42. Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000;95: 3662-8.
43. Avent ND, Martinez A, Flegel WA, Olsson ML, Scott ML, Nogues N, Pisacka M, Daniels GL, Muniz-Diaz E, Madgett TE, Storry JR, Beiboer S, Maaskant-vanWijk PM, von Zabern I, Jiménez E, Tejedor D, López M, Camacho E, Cheroutre G, Hacker A, Jinoch P, Svobodova I, van der Schoot E, de Haas M. The Bloodgen Project of the European Union, 2003-2009. Transfus Med Hemother 2009;36: 162-7.
44. Hashmi G, Shariff T, Seul M, Vissavajjhala P, Hue-Roye K, Charles-Pierre D, Lomas-Francis C, Chaudhuri A, Reid ME. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005;45: 680-8.
45. Weber KM, Fueger JT, Piefer CL, Leszczynski LA, Kalvelage ML, Sauer DE, Marchan MG, Pugh TM, Denomme GA. Identifying rare blood donors: a study in on-time high throughput red cell genotyping [abstract]. Transfusion 2010;50(Suppl 1):174A.
46. Flegel WA, Wagner FF, Müller TH, Gassner C. Rh phenotype prediction by DNA typing and its application to practice. Transfus Med 1998;8: 281-302.
47. Reid ME. Applications of DNA-based assays in blood group antigen and antibody identification. Transfusion 2003;43: 1748-57.
48. Westhoff CM. Molecular testing for transfusion medicine. Curr Opin Hematol 2006;13: 471-5.
49. Flegel WA. Blood group genotyping in Germany. Transfusion 2007;47(Suppl 1):47S-53S.
50. Flegel WA, Wagner FF. Genotyping of red blood cell, granulocyte and platelet antigens: current applications in the german-speaking countries. In: Scharf RE, editor. Progress and challenges in transfusion medicine, hemostasis and hemotherapy. 1st ed. Freiburg: Karger; 2008. p. 189-98.
51. Boyle J, Thorpe SJ, Hawkins JR, Lockie C, Fox B, Matejtschuk P, Halls C, Metcalfe P, Rigsby P, Armstrong-Fisher S, Varzi AM, Urbaniak S, Daniels G. International reference reagents to standardise blood group genotyping: evaluation of candidate preparations in an international collaborative study. Vox Sang 2013;2: 144-52.
52. Socher I, Andrei-Selmer C, Bein G, Kroll H, Santoso S. Lowavidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology. Transfusion 2009;49: 943-52.
53. Bakchoul T, Kubiak S, Krautwurst A, Roderfeld M, Siebert HC, Bein G, Sachs UJ, Santoso S. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia. Transfusion 2011;51: 2455-61.
54. Peterson JA, Kanack A, Nayak D, Bougie DW, McFarland JG, Curtis BR, Aster RH. Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy. Transfusion 2013;53: 1309-18.
55. Gassner C, Schmarda A, Nussbaumer W, Schönitzer D. ABO glycosyltransferase genotyping by polymerase-chain reaction using sequence-specific primers. Blood 1996;88: 1852-6.